Hereditary Retinopathies Progress in Development of Genetic and Molecular Therapies /

• Κύριοι συγγραφείς: Humphries, Pete (Συγγραφέας), Humphries, Marian M. (Συγγραφέας), Tam, Lawrence C. S. (Συγγραφέας), Farrar, G. Jane (Συγγραφέας), Kenna, Paul F. (Συγγραφέας), Campbell, Matthew (Συγγραφέας), Kiang, Anna-Sophia (Συγγραφέας)
• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: New York, NY : Springer New York : Imprint: Springer, 2012.
• Σειρά: SpringerBriefs in Genetics, 1
• Θέματα: Medicine.; Human genetics.; Gene therapy.; Ophthalmology.; Biomedicine.; Human Genetics.; Gene Therapy.

The hereditary retinopathy, retinitis pigmentosa (RP), which affects 1 in 3,500 people worldwide, is the most common cause of registered visual handicap among those of the working age in developed countries. RP is a highly variable disorder where patients may develop symptomatic visual loss in early...

Πίνακας περιεχομένων:

• Preface
• Introduction
• Gene-based Medicines directly targeting genetic defects and molecular pathologies common to multiple forms of disease
• Molecular Medicines.